CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly earnings results, demand for Wegovy, drug pipeline outlook, Cagrisema ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.

Ozempic and Wegovy were notable drugs added to the second ... Enter your email in the box and click Sign Me Up. Donna Fuscaldo is the retirement writer at Kiplinger.com. A writer and editor ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could ... significantly," he told CNBC's "Squawk Box Europe." "But the truth is, being on ...

There is also an FDA box warning for thyroid C-cell tumors for ... To learn more about GLP-1 drugs, read our articles on Mounjaro, Wegovy, and Ozempic, including: Medical News Today has strict ...

Boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California.

Thousands of people in Cayman are using ‘skinny jabs’ like Ozempic as a weight loss aid amid an obesity epidemic that is ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper into these ...

Jan 17 (Reuters) - The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's (NOVOb.CO), opens ...

The clinical trial in which Mr. Neilson participated, called SELECT, paved the way for Health Canada’s decision in November to approve Wegovy to reduce the risk of heart attacks – the first ...